Tema 28. Priones - PowerPoint PPT Presentation

1 / 34
About This Presentation
Title:

Tema 28. Priones

Description:

Tema 28. Priones Caracter sticas generales Estructura y ciclo de multiplicaci n. Patogenia. Inmunidad. Cuadros cl nicos. Diagn stico. Tratamiento. – PowerPoint PPT presentation

Number of Views:149
Avg rating:3.0/5.0
Slides: 35
Provided by: J613
Category:
Tags: prion | priones | tema

less

Transcript and Presenter's Notes

Title: Tema 28. Priones


1
Tema 28. Priones
Características generales Estructura y ciclo de
multiplicación. Patogenia. Inmunidad. Cuadros
clínicos. Diagnóstico. Tratamiento.
Epidemiología y Profilaxis. (Viroides)
2
  • Prions and viroids are unconventional infectious
    agents
  • Prionsinfectious proteins that cause a group of
    diseases of the brain and nervous system called
    Transmissible Spongiform Encephalopathies (TSEs)
  • Viroidssmall, pathogenic RNAs that cause
    viruslike diseases in plants

3
Características Priones
  • Proteínas modificadas del hospedador que puede
    transmitir la enfermedad.
  • Prión pequeña partícula infecciosa proteica.
    (PrP stands for proteinaceous infectious
    particle)
  • Humanos
  • Kuru
  • Enfermedad de Creutzfeldt-Jakob (ECJ)
  • Animales
  • Encefalopatía espongiforme bovina (vacas locas)

4
(No Transcript)
5
(No Transcript)
6
Tertiary Structure of PrPc and PrPres
Estructura y ciclo de multiplicación
Two Distinct Conformations of the Prion Protein
7
PRNP gene encodes PrPC
  • PRNP gene located on chromosome 20 of humans
  • Codes for a 254 AA protein.
  • It is unique (no other proteins of similar
    homology in the database)
  • PrPC is targeted via a secretory pathway to the
    cell surface of neurons and other cell types
  • A glycosylinositol phospholipid anchors it into
    the membrane.

8
Biochemical Analysis of the Prion Amino Acid
Sequence
9
Hypothetical Model showing PrPc Involvement in
the Secretory Pathway of Cells
10
Patogenia
  • Incubation period of TSEs (with the exception of
    vCJD) is long (20-56 years)
  • South Fore tribe members still getting Kuru some
    39-56 years after the cessation of cannibalism

11
Histological/Brain Changes of TSEs
Patogenia
  • Infected brains become spongiform (the brain has
    vacuolesclear zones, similar to a sponge)
  • Neuronal loss
  • Astrocystosis (spread of astrocytes to damaged
    tissues in the brain)
  • Amyloid plaquesformation of PrPres threadlike
    aggregates

12
Spongiosis
Brain tissues showing histopathologic changes
found in bovine spongiform encephalopathy.
13
Diagram of the Major Regions of the Human Brain
Affected by the Different TSEs
14
Brain Changes
  • Depending upon what region of the brain is
    affected
  • e.g. memory is affected when the cerebral cortex
    is infected
  • No inflammation or immune defense against prions
    exists
  • Natural proteins (body does not recognize as
    foreign antigens)
  • Prion proteins are only harmful when they are
    converted to PrPres

15
PRIONES
Depósitos de proteínas priónicas
16
Inmunidad
  • None of the TSEs evoke an immune response
  • Prions cause a noninflammatory process that
    results in vacuolation or spongiosis in the gray
    matter of the brain

17
Fore Child with Symptoms of Ambulant Stage
Cuadros Clínicos
A Fore child with symptoms of the ambulant stage
of Kuru.
18
Clinical Signs and Symptoms of Variant
Creutzfeldt-Jakob Disease (Variant CJD)
  • 50 of variant CJD patients die before the age of
    30
  • average age of death is 28
  • Patients suffering from classic CJD die at an
    average of 68 years

19
(No Transcript)
20
Symptoms of Variant CJD
  • Anxiety
  • Memory loss
  • Mood changes
  • Depression
  • Neurological signs
  • Twitching
  • Spasms (jerky movements)
  • Posture and gait abnormalities (motor
    difficulties)

21
Final Symptoms of Variant CJD
  • Loss of speech
  • Stupor
  • Persistent vegetative state (coma)
  • Death (14 months after symptoms appear)

22
Diagnóstico de CJD
  • Most patients referred to a psychiatrist because
    of behavioral changes
  • Definitive diagnosisprion positive
    immunostaining of biopsy material from
  • Tonsil
  • Spleen
  • Lymph nodes
  • Electroencefalografíalooking for slow or
    negative brain wave activity
  • Resonancia magnéticalooking for brain lesions
  • LCRlooking for elevated levels of neuronal,
    astrocytic and glial proteins
  • Elevated levels are a consequence of damage to
    the blood brain barrier

23
Gold Standard of Diagnosis is Postmortem
Examination of Brain Tissues
Detection of PrPres by Western blot analysis.
Samples of human brain tissues from a diseased
individual suspected of variant CJD.
24
Human Genetics Codon 129
  • 50 known mutations in the PRNP gene
  • PRNP codon 129 appears to act as a genetic
    susceptibility factor (codes for methionine or
    valine at position 129 of the PrPC).
  • All people suffering from vCJD acquired through
    consuming prion-contaminated beef products were
    homozygous methionine at codon 129

25
Steps Toward Treatment and Vaccination
  • No drug therapies available.
  • Treatment is supportive
  • No vaccine available
  • PrPC antibodies injected into the brains of mice
    cause neurotoxicity

26
Epidemiología y Profilaxis
  • Prions are highly resistant to routine methods
    of decontamination
  • Not inactivated by proteases, organic solvents,
    alkaline cleaners, ultraviolet radiation,
    ethanol, formaldehyde or extremely high
    temperatures (e.g. greater than 100 oC
    sterilization for one hour at 121 oC in an
    autoclave does not kill prions)

27
Typical Decontamination Protocol that Researchers
Use
  • Tissues, infectious waste, and instruments used
    in the processing of prion-contaminated samples
    are decontaminated in
  • 1 N NaOH or undiluted fresh household bleach
    followed by autoclaving at 132 oC for 4.5 hours

28
ACCIÓN DE LOS AGENTES FÍSICOS Y QUÍMICOS SOBRE
PRIONES.
COMPARACION VIRUS VS PRIONES VIRUS PRION
Filtrable (infeccioso) Sí Si
Presencia Acido Nucleico Sí No
Presencia de proteínas Sí Sí
Desinfección con
Formaldehído Sí No
Proteasas Algunos No
Calor (80ºC) La mayoría No
Radiaciones ionizantes y UV Sí No
29
Transmission
  • Infection
  • diet, vCJD
  • Iatrogenic means (e.g. surgery)
  • Growth hormone injections
  • Corneal transplants
  • Inherited
  • Genetic CJD
  • Gerstmann-Straussler-Scheinker Disease (GSS)
  • Fatal Familial Insomnia (FFI)
  • Sporadic forms
  • CJD

30
Transmission
31
Species Barrier Bovine Spongiform
Encephalopathy (BSE) and Variant
Creutzfeldt-Jakob Disease (Variant CJD)
  • Transmissibility among species is easy
  • Transmission can occur between different species
  • Origin of BSE unclear
  • Accepted hypothesis is that BSE came from cattle
    ingesting scrapie-contaminated bone meal derived
    from sheep offal fed to young calves

32
ENCEFALOPATÍAS ESPONGIFORMES TRANSMISIBLES
  • HOMBRE
  • Kuru.
  • Enfermedad de Creutzfeldt-Jacob (ECJ).
  • Síndrome de Gerstmann-Straussler (ECJ
    hereditaria).
  • Síndrome de insomnio familiar fatal.
  • Nueva variante de la Enfermedad de
    Creutzfeldt-Jacob (nv ECJ).
  • ANIMALES
  • Scrapie.
  • Encefalopatía espongiforme bovina (Enfermedad de
    las vacas locas).

33
nvECJ
  • Consumo de derivados bovinos con EEB amígdalas,
    retina, tejido nervioso.
  • Homocigotos met en el codón 129.
  • Diferencias

nvECJ ECJ
Edad 15-35 55-65
Duración 14 meses 4,5 meses
Predomina Síntomas psiquiátricos Demencia
Alteraciones EEG NO SI
34
ENCEFALOPATÍAS ESPONGIFORMES SUBAGUDASPRIÓN-VIRIÓ
N
  • SIMILITUDES
  • Transmisibles.
  • Muy pequeños.
  • Filtrables.
  • Dependientes de la célula huésped.
  • Sin capacidad de
  • Generar energía.
  • Síntesis proteica.
  • DIFERENCIAS
  • No evidencia de partículas virales.
  • Ácidos nucleicos no detectables.
  • Muy resistentes.
  • No inducen reacción inflamatoria/respuesta
    inmunitaria.
Write a Comment
User Comments (0)
About PowerShow.com